4121.TWO · ROSSMAX
Taiwan · RS rating 44 · As of 2026-10-08
| Price | 13.25 TWD |
|---|---|
| 1-day change | +3.5% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 67 / 60 / 39 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 17 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -81.8% |
| Sales growth Q/Q | +0.9% |
| Distance from 52-week high | +35.0% |
| Market cap (USD) | $33.6M |